The influence of proteolytic enzyme inhibitors on traumatic swelling.
D000818:Animals; D007611:Aprotinin / Q000627:therapeutic use; D001593:Benzyl Compounds / Q000627:therapeutic use; D002056:Burns / Q000150:complications*; D004487:Edema / Q000188:drug therapy / Q000209:etiology*; D004527:Egg Proteins / Q000627:therapeutic use; D005260:Female; D005461:Fluorine; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007511:Ischemia / Q000150:complications*; D051379:Mice; D009088:Mucoproteins / Q000627:therapeutic use; D010936:Plant Extracts / Q000627:therapeutic use; D013450:Sulfones / Q000627:therapeutic use; D013623:Tail / Q000098:blood supply; D013997:Time Factors; D014111:Tourniquets; D014361:Trypsin Inhibitors / Q000627:therapeutic use*
D001593:Benzyl Compounds; D004527:Egg Proteins; D009088:Mucoproteins; D010936:Plant Extracts; D013450:Sulfones; D014361:Trypsin Inhibitors; D005461:Fluorine; D007611:Aprotinin